Exhibit 99.1
Contact: Tim Berryman
Director – Investor Relations
Medical Properties Trust, Inc.
(205) 969-3755
tberryman@medicalpropertiestrust.com
MEDICAL PROPERTIES TRUST, INC. REPORTS NORMALIZED FFO PER
DILUTED SHARE OF $0.32 IN THIRD QUARTER
Represents 19% Increase Compared To Prior Year Quarter
Birmingham, AL – November 5, 2015 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced financial and operating results for the third quarter ended September 30, 2015.
THIRD QUARTER AND RECENT HIGHLIGHTS
| • | Achieved third quarter Normalized Funds from Operations (“FFO”) per diluted share of $0.32, up 19% compared to $0.27 per share reported in the third quarter of 2014; year to date Normalized FFO of $0.91 per share represents a 15% increase over the comparable period last year; |
| • | Completed previously disclosed $900 million Capella transactions on August 31st; |
| • | Completed two transactions involving Prime Healthcare for an aggregate investment of approximately $130 million; |
| • | Closed on the previously disclosed joint venture for the development of a general acute care hospital in Valencia, Spain; |
| • | Completed construction of six Adeptus First Choice ER facilities (“Adeptus”), including five freestanding ER’s and a general acute care hospital, and commenced collection of rent; MPT is now receiving rent from 31 Adeptus facilities with nine more under construction and 14 in pre-construction diligence. |
Included in the financial tables accompanying this press release is information about the Company’s assets and liabilities, net income and reconciliations of net income to FFO and Adjusted Funds from Operations (“AFFO”), all on a basis comparable to 2014 results.
“The long term planning that MPT has done over the last five years is paying tremendous dividends,” said Edward K. Aldag, Jr., Chairman, President and CEO of the Company. “As you
1
look at the results announced today, you see that the plans we put in place years ago continue to strengthen our portfolio in every respect. Our normalized FFO per share for the quarter has more than doubled from where it was five years ago, and we will continue to add shareholder value by selectively acquiring properties that improve the overall quality of our portfolio and achieve added diversification. As we evaluate our current portfolio, we cannot think of a time in our company’s history when our properties have performed better than the present. We have a highly diversified group of operators that in aggregate provide MPT with rent coverage of 3.8 times. While our balance sheet metrics are currently at the higher end of our historical ranges, it is important to note that we are very comfortable continuing our strong performance within those ranges. We will be prudent in considering various initiatives to lower our debt ratios, including potential select assets sales that should serve to demonstrate the value embedded in our portfolio,” said Aldag.
FINANCING TRANSACTIONS
During the third quarter of 2015, MPT issued 28.75 million shares of common stock for net proceeds of approximately $337.1 million and issued €500 million of 4.00% senior notes due in 2022. The proceeds from the two transactions were used primarily to fund the Capella acquisition and European investments, including repayment of Euro-denominated revolver borrowings.
The Company also exercised the accordion feature under its senior unsecured credit facility, which is now comprised of a $1.3 billion senior unsecured revolving credit facility and a $250 million senior unsecured term loan facility. The credit facility has a new accordion feature that allows the Company to expand the size of the facility by up to $400 million to $1.95 billion.
PORTFOLIO UPDATE
MPT invested approximately $1.1 billion during the quarter, including $772 million in hospital real estate and the previously disclosed approximately $300 million acquisition of interests in Capella Holdings, Inc. In addition, MPT provided $14 million equivalent initial funding of a hospital development project in Valencia, Spain pursuant to the AXA relationship and funded mortgage loans with options to purchase two Prime hospitals for an aggregate $130 million. Furthermore, MPT invested approximately $28 million in Adeptus developments. Five new Adeptus freestanding emergency facilities and one acute care hospital with an aggregate cost of $60 million were placed in service during the quarter.
Also, in the third quarter, MPT sold a long-term acute care facility and six wellness centers for approximately $19.2 million, resulting in gains of approximately $3.3 million ($1.4 million, net of certain write-offs).
As of September 30, 2015, the Company had total gross assets of approximately $5.9 billion including 187 properties in 29 states and in Germany, the United Kingdom and Spain. The properties are leased to or mortgaged by 30 hospital operating companies.
2
OPERATING RESULTS AND OUTLOOK
Normalized FFO for the third quarter increased 56% to $72.5 million compared with $46.6 million in the third quarter of 2014. Per share Normalized FFO increased 19% to $0.32 per diluted share in the third quarter compared with $0.27 per share in the third quarter of 2014.
Third quarter 2015 total revenues increased 42% to $114.6 million compared with $80.8 million for the third quarter of 2014.
Net income for the third quarter of 2015 was $23.1 million (or $0.10 per diluted share), compared to $28.5 million (or $0.16 per diluted share) in the third quarter of 2014; 2015 results include the impact of $29.0 million, or $0.13 per diluted share, of increased acquisition costs and financing fees primarily related to the MEDIAN and Capella acquisitions.
Based solely on the completed and pending acquisitions, development projects currently ongoing, which excludes the $250 million commitment to Adeptus, per share Normalized FFO is expected to range between approximately $1.30 and $1.33 on an annual run-rate basis. This estimate does not include potential earnings from MPT’s equity investment in Capella.
These estimates also do not include the effects, if any, of real estate operating costs, litigation costs, debt refinancing costs, acquisition costs, currency exchange rate movements, interest rate hedging activities, write-offs of straight-line rent or other non-recurring or unplanned transactions. These estimates will change when the Company acquires or sells assets, market interest rates change, debt is refinanced, new shares are issued, additional debt is incurred, other operating expenses vary, income from investments in tenant operations vary from expectations, or existing leases do not perform in accordance with their terms.
CONFERENCE CALL AND WEBCAST
The Company has scheduled a conference call and webcast for Thursday, November 5, 2015 at 11:00 a.m. Eastern Time to present the Company’s financial and operating results for the quarter ended September 30, 2015. The dial-in numbers for the conference call are 877-703-6108 (U.S.) and 857-244-7307 (international); both numbers require passcode 24343193. The conference call will also be available via webcast in the Investor Relations’ section of the Company’s website, www.medicalpropertiestrust.com.
A telephone and webcast replay of the call will be available beginning shortly after the call’s completion through November 19, 2015. Dial-in numbers for the replay are 888-286-8010 and 617-801-6888 for U.S. and International callers, respectively. The replay passcode for both U.S. and international callers is 28924157.
The Company’s supplemental information package for the current period will also be available on the Company’s website under the “Investor Relations” section.
About Medical Properties Trust, Inc.
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. For more information, please visit the Company’s website at www.medicalpropertiestrust.com.
3
The statements in this press release that are forward looking are based on current expectations and actual results or future events may differ materially. Words such as “expects,” “believes,” “anticipates,” “intends,” “will,” “should” and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: ; the satisfaction of all conditions to, and the timely closing (if at all) of pending transactions; Normalized FFO per share;, the amount of acquisitions of healthcare real estate, if any; results from the potential sales, if any, of assets; capital markets conditions, the repayment of debt arrangements; statements concerning the additional income to the Company as a result of ownership interests in certain hospital operations and the timing of such income; the payment of future dividends, if any; completion of additional debt arrangements, and additional investments; national and international economic, business, real estate and other market conditions; the competitive environment in which the Company operates; the execution of the Company’s business plan; financing risks; the Company’s ability to maintain its status as a REIT for federal income tax purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or healthcare real estate in particular. For further discussion of the factors that could affect outcomes, please refer to the “Risk factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2014, and as updated by the Company’s subsequently filed Quarterly Reports on Form 10-Q and other SEC filings. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this press release.
# # #
4
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
| (Amounts in thousands, except for per share data) | September 30, 2015 | December 31, 2014 | ||||||
| Assets |
(Unaudited | ) | ||||||
| Real estate assets |
||||||||
| Land, buildings and improvements, and intangible lease assets |
$ | 3,166,854 | $ | 2,149,612 | ||||
| Construction in progress and other |
39,202 | 23,163 | ||||||
| Net investment in direct financing leases |
618,493 | 439,516 | ||||||
| Mortgage loans |
762,584 | 397,594 | ||||||
|
|
|
|
|
|||||
| Gross investment in real estate assets |
4,587,133 | 3,009,885 | ||||||
| Accumulated depreciation and amortization |
(239,950 | ) | (202,627 | ) | ||||
|
|
|
|
|
|||||
| Net investment in real estate assets |
4,347,183 | 2,807,258 | ||||||
| Cash and cash equivalents |
332,235 | 144,541 | ||||||
| Interest and rent receivables |
47,153 | 41,137 | ||||||
| Straight-line rent receivables |
73,976 | 59,128 | ||||||
| Other assets |
832,776 | 695,272 | ||||||
|
|
|
|
|
|||||
| Total Assets |
$ | 5,633,323 | $ | 3,747,336 | ||||
|
|
|
|
|
|||||
| Liabilities and Equity |
||||||||
| Liabilities |
||||||||
| Debt, net |
$ | 3,364,119 | $ | 2,201,654 | ||||
| Accounts payable and accrued expenses |
123,888 | 112,623 | ||||||
| Deferred revenue |
21,594 | 27,207 | ||||||
| Lease deposits and other obligations to tenants |
11,119 | 23,805 | ||||||
|
|
|
|
|
|||||
| Total Liabilities |
3,520,720 | 2,365,289 | ||||||
| Equity |
||||||||
| Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding |
— | — | ||||||
| Common stock, $0.001 par value. Authorized 500,000 shares; issued and outstanding — 236,656 shares at September 30, 2015 and 172,743 shares at December 31, 2014 |
236 | 172 | ||||||
| Additional paid in capital |
2,591,234 | 1,765,381 | ||||||
| Distributions in excess of net income |
(423,874 | ) | (361,330 | ) | ||||
| Accumulated other comprehensive loss |
(59,731 | ) | (21,914 | ) | ||||
| Treasury shares, at cost |
(262 | ) | (262 | ) | ||||
|
|
|
|
|
|||||
| Total Medical Properties Trust, Inc. Stockholders’ Equity |
2,107,603 | 1,382,047 | ||||||
|
|
|
|
|
|||||
| Non-controlling interests |
5,000 | — | ||||||
|
|
|
|
|
|||||
| Total Equity |
2,112,603 | 1,382,047 | ||||||
|
|
|
|
|
|||||
| Total Liabilities and Equity |
$ | 5,633,323 | $ | 3,747,336 | ||||
|
|
|
|
|
|||||
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Statements of Income
(Unaudited)
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| September 30, 2015 | September 30, 2014 | September 30, 2015 | September 30, 2014 | |||||||||||||
| Revenues |
||||||||||||||||
| Rent billed |
$ | 70,358 | $ | 48,063 | $ | 177,351 | $ | 136,952 | ||||||||
| Straight-line rent |
5,023 | 5,282 | 15,003 | 10,648 | ||||||||||||
| Income from direct financing leases |
14,692 | 12,308 | 40,055 | 36,787 | ||||||||||||
| Interest and fee income |
24,497 | 15,124 | 77,924 | 46,039 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total revenues |
114,570 | 80,777 | 310,333 | 230,426 | ||||||||||||
| Expenses |
||||||||||||||||
| Real estate depreciation and amortization |
20,016 | 13,354 | 49,728 | 39,485 | ||||||||||||
| Impairment charges |
— | — | — | 50,128 | ||||||||||||
| Property-related |
1,727 | 700 | 2,608 | 1,401 | ||||||||||||
| Acquisition expenses |
24,949 | 4,886 | 56,997 | 7,933 | ||||||||||||
| General and administrative |
10,778 | 8,672 | 32,325 | 25,836 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total operating expenses |
57,470 | 27,612 | 141,658 | 124,783 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Operating income |
57,100 | 53,165 | 168,675 | 105,643 | ||||||||||||
| Interest and other income (expense) |
(33,897 | ) | (24,253 | ) | (86,068 | ) | (69,642 | ) | ||||||||
| Income tax (expense) benefit |
(80 | ) | (249 | ) | (1,018 | ) | (232 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Income from continuing operations |
23,123 | 28,663 | 81,589 | 35,769 | ||||||||||||
| Income (loss) from discontinued operations |
— | — | — | (2 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income |
23,123 | 28,663 | 81,589 | 35,767 | ||||||||||||
| Net income attributable to non-controlling interests |
(66 | ) | (126 | ) | (228 | ) | (192 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income attributable to MPT common stockholders |
$ | 23,057 | $ | 28,537 | $ | 81,361 | $ | 35,575 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Earnings per common share – basic and diluted: |
||||||||||||||||
| Income from continuing operations |
$ | 0.10 | $ | 0.16 | $ | 0.38 | $ | 0.21 | ||||||||
| Income (loss) from discontinued operations |
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income attributable to MPT common stockholders |
$ | 0.10 | $ | 0.16 | $ | 0.38 | $ | 0.21 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Dividends declared per common share |
$ | 0.22 | $ | 0.21 | $ | 0.66 | $ | 0.63 | ||||||||
| Weighted average shares outstanding – basic |
223,948 | 171,893 | 211,659 | 169,195 | ||||||||||||
| Weighted average shares outstanding – diluted |
223,948 | 172,639 | 212,068 | 169,852 | ||||||||||||
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Reconciliation of Net Income to Funds From Operations
(Unaudited)
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| September 30, 2015 | September 30, 2014 | September 30, 2015 | September 30, 2014 | |||||||||||||
| FFO information: |
||||||||||||||||
| Net income attributable to MPT common stockholders |
$ | 23,057 | $ | 28,537 | $ | 81,361 | $ | 35,575 | ||||||||
| Participating securities’ share in earnings |
(265 | ) | (179 | ) | (781 | ) | (584 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income (loss), less participating securities’ share in earnings |
$ | 22,792 | $ | 28,358 | $ | 80,580 | $ | 34,991 | ||||||||
| Depreciation and amortization |
20,016 | 13,354 | 49,728 | 39,485 | ||||||||||||
| Gain on sale of real estate |
(3,268 | ) | — | (3,268 | ) | — | ||||||||||
| Real estate impairment charges |
— | — | — | 5,974 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Funds from operations |
$ | 39,540 | $ | 41,712 | $ | 127,040 | $ | 80,450 | ||||||||
| Write-off straight line rent and other |
3,928 | — | 3,928 | 950 | ||||||||||||
| Unutilized financing fees / debt refinancing costs |
4,080 | — | 4,319 | 290 | ||||||||||||
| Loan and other impairment charges |
— | — | — | 44,154 | ||||||||||||
| Acquisition expenses |
24,949 | 4,886 | 56,997 | 7,933 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Normalized funds from operations |
$ | 72,497 | $ | 46,598 | $ | 192,284 | $ | 133,777 | ||||||||
| Share-based compensation |
2,515 | 2,059 | 7,716 | 6,179 | ||||||||||||
| Debt costs amortization |
1,523 | 1,247 | 4,294 | 3,441 | ||||||||||||
| Additional rent received in advance (A) |
(300 | ) | (300 | ) | (900 | ) | (900 | ) | ||||||||
| Straight-line rent revenue and other |
(9,840 | ) | (6,979 | ) | (23,100 | ) | (16,512 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Adjusted funds from operations |
$ | 66,395 | $ | 42,625 | $ | 180,294 | $ | 125,985 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Per diluted share data: |
||||||||||||||||
| Net income, less participating securities’ share in earnings |
$ | 0.10 | $ | 0.16 | $ | 0.38 | $ | 0.21 | ||||||||
| Depreciation and amortization |
0.09 | 0.08 | 0.23 | 0.22 | ||||||||||||
| Gain on sale of real estate |
(0.01 | ) | — | (0.01 | ) | — | ||||||||||
| Real estate impairment charges |
— | — | — | 0.04 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Funds from operations |
$ | 0.18 | $ | 0.24 | $ | 0.60 | $ | 0.47 | ||||||||
| Write-off straight line rent and other |
0.01 | — | 0.02 | 0.01 | ||||||||||||
| Unutilized financing fees / debt refinancing costs |
0.02 | — | 0.02 | — | ||||||||||||
| Loan and other impairment charges |
— | — | — | 0.26 | ||||||||||||
| Acquisition expenses |
0.11 | 0.03 | 0.27 | 0.05 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Normalized funds from operations |
$ | 0.32 | $ | 0.27 | $ | 0.91 | $ | 0.79 | ||||||||
| Share-based compensation |
0.01 | 0.01 | 0.04 | 0.04 | ||||||||||||
| Debt costs amortization |
0.01 | 0.01 | 0.01 | 0.02 | ||||||||||||
| Additional rent received in advance (A) |
— | — | — | (0.01 | ) | |||||||||||
| Straight-line rent revenue and other |
(0.04 | ) | (0.04 | ) | (0.11 | ) | (0.10 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Adjusted funds from operations |
$ | 0.30 | $ | 0.25 | $ | 0.85 | $ | 0.74 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| (A) | Represents additional rent received from one tenant in advance of when we can recognize as revenue for accounting purposes. This additional rent is being recorded to revenue on a straight-line basis over the lease life. |
Investors and analysts following the real estate industry utilize funds from operations, or FFO, as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or NAREIT, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.
In addition to presenting FFO in accordance with the NAREIT definition, we also disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs necessary to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.
We calculate adjusted funds from operations, or AFFO, by subtracting from or adding to normalized FFO (i) unbilled rent revenue, (ii) non-cash share-based compensation expense, and (iii) amortization of deferred financing costs. AFFO is an operating measurement that we use to analyze our results of operations based on the receipt, rather than the accrual, of our rental revenue and on certain other adjustments. We believe that this is an important measurement because our leases generally have significant contractual escalations of base rents and therefore result in recognition of rental income that is not collected until future periods, and costs that are deferred or are non-cash charges. Our calculation of AFFO may not be comparable to AFFO or similarly titled measures reported by other REITs. AFFO should not be considered as an alternative to net income (calculated pursuant to GAAP) as an indicator of our results of operations or to cash flow from operating activities (calculated pursuant to GAAP) as an indicator of our liquidity.
